Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:dateCreated |
1977-11-30
|
pubmed:language |
fre
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0075-4463
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
207-16
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:910599-Drug Evaluation,
pubmed-meshheading:910599-Female,
pubmed-meshheading:910599-Fetus,
pubmed-meshheading:910599-Humans,
pubmed-meshheading:910599-Hypertension,
pubmed-meshheading:910599-Infant, Newborn,
pubmed-meshheading:910599-Pregnancy,
pubmed-meshheading:910599-Pregnancy Complications,
pubmed-meshheading:910599-Pregnancy Complications, Cardiovascular,
pubmed-meshheading:910599-Propranolol
|
pubmed:year |
1977
|
pubmed:articleTitle |
[Use of beta blockers (propranolol) in the treatment of arterial hypertension during pregnancy].
|
pubmed:publicationType |
Journal Article
|